ArticleTransplantation and cellular therapy2024

Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.

Maria-Stefania Infante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.